This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Etta Biotech”), to set up a high titer transient protein expression platform for high quality proteinproduction using JS Bio’s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech’s transient transfection high titer protein expression platform.
To make matters worse, many companies struggled with engineering problems on the path to scale. Between the technical uncertainty and the horrendous PR, pharmaceuticalcompanies had little interest in adopting molecular farming technologies. Tiamat Sciences harvests a variety of proteinproducts in tobacco plants.
Making medicine The T7 technology has also had immediate impacts in industry, with more than 900 biotech and pharmaceuticalcompanies licensing it to produce therapeutics and vaccines. There are more than 100 different versions of the T7 technology available commercially and 12 patents in Studier’s name related to the system.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content